同仁堂科技（01666.HK）今日盘中大跌6.03%，引发市场关注。截至盘中，该股报价5.01港元，成交额达1835.62万港元。
消息面上，同仁堂科技发布2025年中期业绩报告，显示公司经营业绩出现明显下滑。报告期内，公司实现收入37.39亿元人民币，同比减少7.69%；公司所有者应占净利润3.39亿元，同比大幅下降21.01%。这一业绩表现不及市场预期，成为导致股价下跌的主要原因。
尽管整体业绩下滑，同仁堂科技部分产品线仍保持增长。其中，六味地黄丸系列销售收入同比增长约47.99%，金匮肾气系列增长约19.55%。公司实施的"大品种战略"也取得一定成效，壮腰健肾丸系列、知柏地黄丸系列及归芍地黄丸系列等产品销售收入均实现双位数增长。然而，感冒清热颗粒系列及生脉饮口服液系列销售收入较上年同期有所下降，部分抵消了其他产品的增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.